About Edwards Lifesciences
Edwards Lifesciences is a company based in Irvine (United States) founded in 1958.. The company has 15,800 employees as of December 31, 2024. Edwards Lifesciences has completed 13 acquisitions, including BMEYE, CAS Medical Systems and Corvia Medical. Edwards Lifesciences offers products and services including Transcatheter Heart Valves, Hemodynamic Monitoring, and Surgical Heart Technologies. Edwards Lifesciences operates in a competitive market with competitors including Tyto Care, BioIntelliSense, Endotronix, CoachCare and Lumen, among others.
- Headquarter Irvine, United States
- Employees 15800 as on 31 Dec, 2024
- Stage Public
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Edwards Lifesciences Corporation
-
Annual Revenue
$5.44 B8.57as on Dec 31, 2024
-
Net Profit
$874.6 M-37.64as on Dec 31, 2024
-
EBITDA
$1.6 B1.74as on Dec 31, 2024
-
Latest Funding Round
$34.87 M (USD), Post-IPO
May 25, 2018
-
Investors
-
Employee Count
15800
as on Dec 31, 2024
-
Investments & Acquisitions
BMEYE
& 12 more
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
IPO & Listings of Edwards Lifesciences
Edwards Lifesciences is a publicly listed company on the NYSE with ticker symbol EW in USA, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
Products & Services of Edwards Lifesciences
Edwards Lifesciences offers a comprehensive portfolio of products and services, including Transcatheter Heart Valves, Hemodynamic Monitoring, and Surgical Heart Technologies. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Devices for minimally invasive heart valve treatment and replacement.
Tools for continuous blood pressure and fluid management in critical care.
Advanced tissue solutions for heart surgeries and procedures.
Unlock access to complete
Software Development Team
180 people
Leadership Team
72 people
Sales and Marketing
42 people
Finance and Accounting
38 people
Product Management Team
36 people
Senior Team
32 people
Manager Team
22 people
Legal and Compliance
16 people
Unlock access to complete
Funding Insights of Edwards Lifesciences
- Total Funding Total Funding
- Total Rounds 1
- Last Round Post-IPO — $34.9M
-
First Round
First Round
(25 May 2018)
- Investors Count Investors Count
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| May, 2018 | Amount | Post-IPO - Edwards Lifesciences | Valuation |
investors |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investments & Acquisitions by Edwards Lifesciences
Edwards Lifesciences has strategically engaged in corporate development activities, having acquired 13 companies. Notable acquisitions include BMEYE, CAS Medical Systems and Corvia Medical. These strategic investments and acquisitions demonstrate the company's commitment to growth through portfolio expansion, market consolidation, technology integration, and strategic partnerships that enhance competitive positioning and drive long-term value creation.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Catheter-delivered heart valve therapies are developed for replacement and repair.
|
2017 | ||||
|
Transcatheter Aortic Valve Implantation systems are developed for aortic conditions.
|
2014 | ||||
|
Minimally invasive mitral valve repair device is developed.
|
2013 |
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
OVO is recognized as a smart digital payment application.
|
2017 | ||||
|
Bionic investment advisor platform
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 |
Financial Statements - Edwards Lifesciences
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Edwards Lifesciences Comparisons
Competitors of Edwards Lifesciences
Edwards Lifesciences operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Tyto Care, BioIntelliSense, Endotronix, CoachCare and Lumen, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Medical consultations are facilitated via self-exams and remote diagnostic devices.
|
|
| domain | founded_year | HQ Location |
Vital signs are monitored via a single-use patch and platform.
|
|
| domain | founded_year | HQ Location |
Miniaturized wireless implantable sensors are developed for hemodynamic monitoring.
|
|
| domain | founded_year | HQ Location |
Remote monitoring platform for tracking patient activity
|
|
| domain | founded_year | HQ Location |
Breath-based metabolism tracker for personalized diet plans is provided.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Edwards Lifesciences
Frequently Asked Questions about Edwards Lifesciences
When was Edwards Lifesciences founded?
Edwards Lifesciences was founded in 1958 and raised its 1st funding round 60 years after it was founded.
Where is Edwards Lifesciences located?
Edwards Lifesciences is headquartered in Irvine, United States. It is registered at Irvine, California, United States.
How many employees does Edwards Lifesciences have?
As of Dec 31, 2024, the latest employee count at Edwards Lifesciences is 15,800.
What is the annual revenue of Edwards Lifesciences?
Annual revenue of Edwards Lifesciences is $5.44B as on Dec 31, 2024.
What does Edwards Lifesciences do?
Edwards Lifesciences was founded in 1958 and is headquartered in Irvine, United States. Operations focus on the healthcare sector, where medical devices for structural heart disease are developed. Products include tissue replacement heart valves, repair items, transcatheter heart valves, and hemodynamic monitoring systems. These offerings support treatments in cardiovascular care across global markets.
Who are the top competitors of Edwards Lifesciences?
Edwards Lifesciences's top competitors include Tyto Care, Endotronix and BioIntelliSense.
What products or services does Edwards Lifesciences offer?
Edwards Lifesciences offers Transcatheter Heart Valves, Hemodynamic Monitoring, and Surgical Heart Technologies.
Is Edwards Lifesciences publicly traded?
Yes, Edwards Lifesciences is publicly traded on NYSE under the ticker symbol EW.
How many acquisitions has Edwards Lifesciences made?
Edwards Lifesciences has made 13 acquisitions, including BMEYE, CAS Medical Systems, and Corvia Medical.
What is Edwards Lifesciences's ticker symbol?
The ticker symbol of Edwards Lifesciences is EW on NYSE.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.